Expertise in
7
conditions

Quentin Denost

Bordeaux, FR 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
7
conditions
Bordeaux, FR 

Overview

Quentin Denost practices practicing medicine in Bordeaux, France.

Mr. Denost is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Endometriosis, Crohn's Disease, Ileostomy, and Colostomy.

He is actively involved in clinical research, co-authoring 164 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Bordeaux, France
Other Locations
208 Av Des Apothicaires, Montpellier, 34090, France
Pessac-sur-dordogne, France
Lyon, France
CHU Lille
Lille, France
Saint-andre-de-rosans, France
184, Rue Du Faubourg Saint Antoine, Paris, 75012, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Low Impact Laparoscopic in Colorectal Resection: a Randomized Trial Comparing Low Pneumoperitoneum Pressure Plus Microsurgery Versus Low Pneumoperitoneum Alone
Low Impact Laparoscopic in Colorectal Resection: a Randomized Trial Comparing Low Pneumoperitoneum Pressure Plus Microsurgery Versus Low Pneumoperitoneum Alone
Enrollment Status: Recruiting
Publish Date: May 22, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
A Phase III Randomized Trial Evaluating the Tailored Versus the Systematic Use of Defunctioning Stoma After Total Mesorectal Excision for Rectal Cancer
A Phase III Randomized Trial Evaluating the Tailored Versus the Systematic Use of Defunctioning Stoma After Total Mesorectal Excision for Rectal Cancer
Enrollment Status: Recruiting
Publish Date: May 16, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Reduction by Pasireotide of the Effluent Volume in High-output Enterostomy in Patients Refractory to Usual Medical Treatment : Phase II Multicentric Randomized Double Bland Placebo Controlled Study
Reduction by Pasireotide of the Effluent Volume in High-output Enterostomy in Patients Refractory to Usual Medical Treatment : Phase II Multicentric Randomized Double Bland Placebo Controlled Study
Enrollment Status: Completed
Publish Date: December 19, 2025
Intervention Type: Drug
Study Drug: Pasireotide
Study Phase: Phase 2
A Phase III Randomized Trial Evaluating Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer (GRECCAR - PRODIGE - FRENCH)
A Phase III Randomized Trial Evaluating Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer (GRECCAR - PRODIGE - FRENCH)
Enrollment Status: Active_not_recruiting
Publish Date: August 14, 2024
Intervention Type: Procedure, Drug, Radiation
Study Phase: Phase 3
Benchmarking Trial Between France and Australia Comparing Management of Primary Rectal Cancer Beyond TME (Total Mesorectum Excision) and Locally Recurrent Rectal Cancer
Benchmarking Trial Between France and Australia Comparing Management of Primary Rectal Cancer Beyond TME (Total Mesorectum Excision) and Locally Recurrent Rectal Cancer
Enrollment Status: Completed
Publish Date: August 09, 2018
Intervention Type: Other
View 3 Less Clinical Trials

164 Total Publications

Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers.
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 06, 2026

Frequently Asked Questions about Quentin Denost

Is Quentin Denost a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Quentin Denost is classified as an Distinguished expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Quentin Denost participate in research or clinical trials?

Yes. Quentin Denost has published 164 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Quentin Denost's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Denost's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile